top of page
Biotech Stories, News & Events

Similar Stories from FIB

Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A 
13/01/25
Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A 
Sartar Therapeutics: A New Precision Therapy for Rare Soft Tissue Cancers
14/12/24
Sartar Therapeutics: A New Precision Therapy for Rare Soft Tissue Cancers
Finnish Bioindustries warmly welcomes Synbio Powerlabs as its newest member!
14/10/24
Finnish Bioindustries warmly welcomes Synbio Powerlabs as its newest member!
A new global gene therapy manufacturing facility boosts healthcare innovation in Finland
03/10/24
A new global gene therapy manufacturing facility boosts healthcare innovation in Finland
bottom of page